Genenta Science S.p.A. (NASDAQ: GNTA) Stock Information | RedChip

Genenta Science S.p.A. (NASDAQ: GNTA) Listen to this Section


$4.39
+0.2200 ( +5.28% ) 0.7K

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Market Data


Open


$4.39

Previous close


$4.17

Volume


0.7K

Market cap


$77.33M

Day range


$4.17 - $4.30

52 week range


$2.20 - $5.90

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 May 03, 2024
6-k Quarterly Reports 4 Apr 26, 2024
6-k Quarterly Reports 1 Apr 08, 2024
6-k Quarterly Reports 2 Apr 02, 2024
20-f/a Annual reports 20 Apr 01, 2024
20-f Annual reports 95 Mar 29, 2024
6-k Quarterly Reports 98 Oct 20, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.